CDC suggests ways to increase CRC screening rates

November 6, 2013
CDC suggests ways to increase CRC screening rates

(HealthDay)—Various approaches should be implemented to increase the use of colorectal cancer (CRC) screening tests, according to the November issue of the U.S. Centers for Disease Control and Prevention's Vital Signs.

Noting that CRC is the second leading cancer killer of U.S. men and women and that about 90 percent of people live five or more years when CRC is found early through testing, researchers from the CDC looked at ways to increase testing.

According to the report, about one in three adults (28 percent; 23 million) aged 50 to 75 years are not getting tested as recommended, and most of these adults (76 percent) are insured. To increase testing, should offer recommended test options ( test [FOBT], [FIT], and sigmoidoscopy), with information about each test; match patients with the tests they are most likely to complete; work with health professionals to increase testing via hiring and training of patient navigators; and create ways to make it easy to get FOBT/FIT kits in places other than the doctor's office.

"Testing saves lives, but only if people get tested. Studies show that people who are able to pick the test they prefer are more likely to actually get the test done. Increasing the use of all recommended tests can save more lives and is cost-effective," according to the report.

Explore further: Hybrid screening strategy emerges for colorectal cancer

More information: More Information

Related Stories

Hybrid screening strategy emerges for colorectal cancer

August 27, 2013
A strategy that combines two effective colorectal cancer screening methods, fecal immunological test and colonoscopy, may improve prevention and detection of colorectal cancer and reduce costs, according to a new study in ...

Effect of mailed outreach invitations to underserved patients for colorectal cancer screening

August 5, 2013
Among underserved patients whose colorectal cancer (CRC) screening was not up to date, mailed outreach invitations appear to result in higher CRC screening compared with usual care, according to a study by Samir Gupta, M.D., ...

Biomarker identification may lead to new noninvasive test for colorectal cancer detection

June 7, 2013
The average 5-year survival for colorectal cancer (CRC) is less than 10% if metastasis occurs, but can reach 90% if detected early. A new non-invasive test has been developed that measures methylation of the SDC2 gene in ...

Inclusion of CTC as HEDIS screening modality could increase colorectal cancer screening compliance

January 10, 2013
Availability of CT colonography (CTC), commonly known as virtual colonoscopy, is increasing colorectal cancer (CRC) screening rates across military medical facilities. Inclusion of CTC as a Healthcare Effectiveness Data and ...

A recipe for increased colorectal cancer screening rates

August 14, 2012
Screening for colorectal cancer (CRC) is cost-effective and saves lives by early detection. The ability to screen large numbers of individuals is especially important for states with tight health insurance budgets dealing ...

Colon cancer testing may be leveling off in US

November 5, 2013
After years of increases, testing for colon cancer may be leveling off.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.